Post-approval studies (Phase 4)UnknownNCT01453933What this trial is testingRAltegravir Switch STudy: Effects on Endothelial RecoveryWho this might be right forHIV InfectionEndothelial Dysfunction UMC Utrecht 24
Not applicableNot Yet RecruitingNCT07645378What this trial is testingFeasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaWho this might be right forHIV (Human Immunodeficiency Virus)HPVCervical Precancer+1 more Fred Hutchinson Cancer Center 200
Not applicableEnded earlyNCT00341887What this trial is testingEpidemiological Study of HIV in the South African National Defense ForceWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 8,676
Testing effectiveness (Phase 2)Study completedNCT00680147What this trial is testingHuman Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial BarriersWho this might be right forHPV Syracuse University 614
Testing effectiveness (Phase 2)Study completedNCT00000838What this trial is testingAntiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 256
Not applicableStudy completedNCT00602758What this trial is testingEffectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIVWho this might be right forHIV InfectionsAcquired Immunodeficiency Syndrome University of Missouri, Kansas City 252
Not applicableStudy completedNCT02481492What this trial is testingRandomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip TechniqueWho this might be right forHuman Immunodeficiency Virus Ningbo No. 1 Hospital 100
Post-approval studies (Phase 4)Study completedNCT00240552What this trial is testingFosamprenavir Expanded AccessWho this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 85
Testing effectiveness (Phase 2)UnknownNCT00622232What this trial is testingA Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 TrialWho this might be right forHIV Infections VIRxSYS Corporation 40
Post-approval studies (Phase 4)Ended earlyNCT00414284What this trial is testingBOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)Who this might be right forHIV Infections Community Research Initiative of New England
Testing effectiveness (Phase 2)Study completedNCT00033163What this trial is testingA Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVWho this might be right forHIV InfectionsHepatitis B National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT00001021What this trial is testingA Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)Study completedNCT01900106What this trial is testingA Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)Who this might be right forHIV Infection University of Modena and Reggio Emilia 47
Not applicableStudy completedNCT00904384What this trial is testingPrevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ PatientsWho this might be right forHIV InfectionsCOPD Cimera 350
Large-scale testing (Phase 3)Study completedNCT00001649What this trial is testingValaciclovir to Prevent Transmission of Herpes Simplex VirusWho this might be right forHerpes Simplex National Institute of Allergy and Infectious Diseases (NIAID) 180
Post-approval studies (Phase 4)UnknownNCT04746547What this trial is testingPharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TBWho this might be right forTuberculosisHiv University of KwaZulu 20
Early research (Phase 1)Study completedNCT00119873What this trial is testingSafety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00184951What this trial is testingPharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV PatientsWho this might be right forHIV InfectionsHyperlipidemia Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00001031What this trial is testingA Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT00014053What this trial is testingImmune System Activity in Healthy AdultsWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 48